Is AOD-9604 FDA-Approved?

AOD-9604 is not FDA-approved. The FDA has never approved this growth hormone fragment for any human use, and it appears on the agency's list of bulk drug substances that may present significant safety risks and are therefore not eligible for 503A compounding. Every AOD-9604 product sold in the United States today is labeled for research use only, not as an approved medication.

That one fact answers the headline question, but it raises a few more: what the peptide is actually used for, whether it works, and where it sits legally.

What AOD-9604 Is and Why It Was Never Approved

AOD-9604 is a synthetic fragment of human growth hormone, specifically the C-terminal portion known as hGH 176-191. It was engineered to mimic the piece of growth hormone thought to influence fat metabolism while leaving out the portions tied to growth and blood sugar effects.

Australian researchers developed it in the 1990s as a potential obesity drug. It advanced into Phase II trials for obesity and later for knee osteoarthritis, but the results were not strong enough to justify further development, and the program was discontinued.

AOD-9604 is not FDA-approved because no sponsor has submitted the safety and efficacy data required for approval, and the clinical results to date have not supported that investment.

What AOD-9604 Is Marketed For

Ask what is aod 9604 used for and most sellers describe it as a "fat-burning" peptide. It also shows up in anti-aging and body-composition circles, often stacked with other peptides.

None of those uses are FDA-reviewed or FDA-approved. Marketing claims about fat loss for an unapproved peptide are not backed by the kind of evidence the agency requires.

• Research use: the only framing most US vendors put on the label.
• Fat loss and body composition: the most common consumer claim, based largely on early animal studies and small human trials.
• Osteoarthritis and joint health: studied in a Phase II knee osteoarthritis trial that never led to an approved product.

AOD-9604 Compared With Other Peptides and Weight-Loss Drugs

Approval status varies widely across the compounds people ask about. The table below shows where AOD-9604 sits next to a few common comparisons.

A closely related question is is cjc-1295/ipamorelin fda-approved, and that answer is also no. Neither peptide in that pair has an approved human indication in the United States.

Is AOD-9604 Legal in the US?

If you are asking is aod-9604 legal, the answer depends on what you mean. AOD-9604 is not a DEA-scheduled controlled substance, so possession alone is not a federal drug crime the way possession of anabolic steroids without a prescription can be.

Selling it for human consumption is a different story. Introducing an unapproved new drug into interstate commerce violates the federal Food, Drug, and Cosmetic Act, and the FDA has sent warning letters to peptide vendors over exactly this practice. Vendors protect themselves by labeling products "for research use only, not for human consumption."

AOD-9604 is also banned in sport. The World Anti-Doping Agency lists growth hormone fragments, including AOD-9604, as prohibited substances at all times.

Does AOD-9604 Work? What the Trials Show

Whether you phrase the search as is aod 9604 effective or simply "does it burn fat," the best available evidence is modest. In a 12-week Phase IIb trial in obese adults, participants on AOD-9604 lost slightly more weight than the placebo group, but the difference was small and did not reach statistical significance.

The knee osteoarthritis trial produced similarly underwhelming results, which is why the drug was never filed for approval in any country.

Search interest in when is the best time to take aod 9604 is high, but there is no FDA-reviewed dosing schedule because there is no approved product. Timetables shared online come from vendors and user forums, not from controlled clinical research.

Safety and Sourcing Risks to Know

Peptides bought online are not held to pharmaceutical manufacturing standards. There is no independent guarantee of identity, purity, or sterility, and mislabeled or contaminated vials are a recurring problem in this market.

Reported side effects in AOD-9604 trials were generally mild, including injection-site reactions and headache, but the trials were short and small. Long-term safety data in humans do not exist.

Because AOD-9604 is not FDA-approved, no US health agency has verified that any marketed version is safe, effective, or even contains what the label says.

If weight management is the goal, FDA-approved options prescribed by a clinician come with regulated dosing, monitoring, and real safety data. Anyone considering a research peptide should talk with a healthcare professional first.